RAPT Therapeutics Statistics Share Statistics RAPT Therapeutics has 16.54M
shares outstanding. The number of shares has increased by 0.02%
in one year.
Shares Outstanding 16.54M Shares Change (YoY) 0.02% Shares Change (QoQ) 0.01% Owned by Institutions (%) 35.11% Shares Floating 8.37M Failed to Deliver (FTD) Shares 296 FTD / Avg. Volume 0.2%
Short Selling Information The latest short interest is 412.05K, so 2.49% of the outstanding
shares have been sold short.
Short Interest 412.05K Short % of Shares Out 2.49% Short % of Float 3.01% Short Ratio (days to cover) 3.64
Valuation Ratios The PE ratio is -3.97 and the forward
PE ratio is -8.84.
RAPT Therapeutics's PEG ratio is
-0.86.
PE Ratio -3.97 Forward PE -8.84 PS Ratio 0 Forward PS 47.2 PB Ratio 2.71 P/FCF Ratio -6.18 PEG Ratio -0.86
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for RAPT Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.87,
with a Debt / Equity ratio of 0.02.
Current Ratio 4.87 Quick Ratio 4.87 Debt / Equity 0.02 Debt / EBITDA -0.04 Debt / FCF -0.05 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.94M Employee Count 67 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 82.79% in the
last 52 weeks. The beta is 0.23, so RAPT Therapeutics's
price volatility has been higher than the market average.
Beta 0.23 52-Week Price Change 82.79% 50-Day Moving Average 14.78 200-Day Moving Average 10.39 Relative Strength Index (RSI) 87.42 Average Volume (20 Days) 150,465
Income Statement
Revenue n/a Gross Profit n/a Operating Income -136.1M Net Income -129.87M EBITDA -126.33M EBIT -129.87M Earnings Per Share (EPS) -3.19
Full Income Statement Balance Sheet The company has 169.74M in cash and 4.49M in
debt, giving a net cash position of 165.24M.
Cash & Cash Equivalents 169.74M Total Debt 4.49M Net Cash 165.24M Retained Earnings -614.55M Total Assets 178.41M Working Capital 159.82M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -83.3M
and capital expenditures -122K, giving a free cash flow of -83.42M.
Operating Cash Flow -83.3M Capital Expenditures -122K Free Cash Flow -83.42M FCF Per Share -2.05
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields RAPT does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for RAPT is $32,
which is 10% higher than the current price. The consensus rating is "Buy".
Price Target $32 Price Target Difference 10% Analyst Consensus Buy Analyst Count 6
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 17, 2025. It was a
backward
split with a ratio of 1:8.
Last Split Date Jun 17, 2025 Split Type backward Split Ratio 1:8
Scores Altman Z-Score 8.19 Piotroski F-Score 4
